SG10201809450VA - Heterogeneous polypeptide expression cassette - Google Patents
Heterogeneous polypeptide expression cassetteInfo
- Publication number
- SG10201809450VA SG10201809450VA SG10201809450VA SG10201809450VA SG10201809450VA SG 10201809450V A SG10201809450V A SG 10201809450VA SG 10201809450V A SG10201809450V A SG 10201809450VA SG 10201809450V A SG10201809450V A SG 10201809450VA SG 10201809450V A SG10201809450V A SG 10201809450VA
- Authority
- SG
- Singapore
- Prior art keywords
- bacterium
- expression cassette
- heterogeneous polypeptide
- genus bifidobacterium
- heterogeneous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/36—Vector systems having a special element relevant for transcription being a transcription termination element
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
HETEROGENEOUS POLYPEPTIDE EXPRESSION CASSETTE An object is to provide a signal peptide that can secrete a heterogeneous polypeptide with high efficiency outside the bacterial cell in a bacterium of the genus Bifidobacterium, an expression cassette that can secrete a heterogeneous polypeptide with high efficiency outside the bacterial cell, a heterogeneous polypeptide expression vector, a bacterium of the genus Bifidobacterium capable of secreting a heterogeneous polypeptide. Means for attaining the object is a bacterium of the genus Bifidobacterium transformed by a vector having an expression cassette sequentially comprising a promoter DNA functioning in a bacterium of the genus Bifidobacterium, a DNA encoding the secretory signal peptide, a DNA encoding a scFv antibody having an antitumor activity, and a terminator DNA functioning in the bacterium of the genus Bifidobacterium; and capable of secreting the scFv antibody with high efficiency outside the bacterial cell. [No suitable Figure]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014094869 | 2014-05-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201809450VA true SG10201809450VA (en) | 2018-11-29 |
Family
ID=54358386
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201609032WA SG11201609032WA (en) | 2014-05-01 | 2015-04-17 | Heterogeneous polypeptide expression cassette |
SG10201809450VA SG10201809450VA (en) | 2014-05-01 | 2015-04-17 | Heterogeneous polypeptide expression cassette |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201609032WA SG11201609032WA (en) | 2014-05-01 | 2015-04-17 | Heterogeneous polypeptide expression cassette |
Country Status (8)
Country | Link |
---|---|
US (1) | US10443061B2 (en) |
EP (1) | EP3141602A4 (en) |
JP (1) | JP6634625B2 (en) |
KR (1) | KR20170002403A (en) |
CN (1) | CN107002090B (en) |
CA (1) | CA2947525C (en) |
SG (2) | SG11201609032WA (en) |
WO (1) | WO2015166640A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3138907B1 (en) | 2014-05-02 | 2020-02-26 | Shinshu University | Antibody gene expression-secretion system |
JP6755465B2 (en) | 2014-12-03 | 2020-09-16 | 株式会社アネロファーマ・サイエンス | Co-expression plasmid |
SG11201705915VA (en) | 2015-01-19 | 2017-08-30 | Univ Shinshu | Therapeutic agent for ischemic diseases |
EP3402498A1 (en) | 2016-01-11 | 2018-11-21 | Synlogic, Inc. | Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells |
JP2020505016A (en) * | 2017-01-06 | 2020-02-20 | シンロジック オペレーティング カンパニー インコーポレイテッド | Microorganisms programmed to produce immunomodulators and anticancer therapeutics in tumor cells |
US20220281998A1 (en) | 2019-08-28 | 2022-09-08 | Azusapharma Sciences, Inc. | Bifidobacterium spp. expressing and secreting diabody-type bsab |
CN110747154A (en) * | 2019-09-17 | 2020-02-04 | 广州维生君生物科技有限公司 | PD-1 humanized single-chain antibody fusion gene transformed lactic acid bacteria and application thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6051227A (en) * | 1995-07-25 | 2000-04-18 | The Regents Of The University Of California, Office Of Technology Transfer | Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
DE10101793A1 (en) * | 2001-01-17 | 2002-08-01 | Manfred Nilius | Use of SLPI to treat inflammatory bowel disease |
EP1227152A1 (en) | 2001-01-30 | 2002-07-31 | Société des Produits Nestlé S.A. | Bacterial strain and genome of bifidobacterium |
IL149701A0 (en) * | 2001-05-23 | 2002-11-10 | Pfizer Prod Inc | Use of anti-ctla-4 antibodies |
EP1445264B1 (en) * | 2001-07-31 | 2011-09-14 | Ono Pharmaceutical Co., Ltd. | Substance specific to pd-1 |
JP4945440B2 (en) | 2005-04-08 | 2012-06-06 | 株式会社アネロファーマ・サイエンス | 5-Fluorouracil resistant bacteria and production method thereof |
US9730968B2 (en) * | 2008-04-17 | 2017-08-15 | Anaeropharma Science, Inc. | Therapeutic agent for ischemic diseases |
JPWO2010126073A1 (en) | 2009-04-28 | 2012-11-01 | 協和発酵キリン株式会社 | Expression cassette for the secretory expression of polypeptides and uses thereof |
CN101608172B (en) * | 2009-07-24 | 2013-01-23 | 南京华贞生物医药科技有限公司 | Transformant for reducing weight and fat and preparation method thereof |
JP5841432B2 (en) | 2010-01-29 | 2016-01-13 | 株式会社アネロファーマ・サイエンス | Plasmid for transformation |
EP2873726B1 (en) | 2012-07-13 | 2018-09-05 | Teikyo Heisei University | Antitumor agent, marker for tumor detection, and oral vaccine agent |
-
2015
- 2015-04-17 SG SG11201609032WA patent/SG11201609032WA/en unknown
- 2015-04-17 JP JP2016515853A patent/JP6634625B2/en active Active
- 2015-04-17 SG SG10201809450VA patent/SG10201809450VA/en unknown
- 2015-04-17 CA CA2947525A patent/CA2947525C/en active Active
- 2015-04-17 WO PCT/JP2015/002132 patent/WO2015166640A1/en active Application Filing
- 2015-04-17 EP EP15785407.6A patent/EP3141602A4/en active Pending
- 2015-04-17 KR KR1020167030618A patent/KR20170002403A/en not_active Application Discontinuation
- 2015-04-17 CN CN201580029678.5A patent/CN107002090B/en active Active
- 2015-04-17 US US15/308,179 patent/US10443061B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2947525C (en) | 2023-09-05 |
EP3141602A1 (en) | 2017-03-15 |
CN107002090A (en) | 2017-08-01 |
CN107002090B (en) | 2021-09-10 |
CA2947525A1 (en) | 2015-11-05 |
WO2015166640A1 (en) | 2015-11-05 |
JP6634625B2 (en) | 2020-01-22 |
KR20170002403A (en) | 2017-01-06 |
SG11201609032WA (en) | 2016-12-29 |
US20170183667A1 (en) | 2017-06-29 |
JPWO2015166640A1 (en) | 2017-04-20 |
EP3141602A4 (en) | 2017-11-29 |
US10443061B2 (en) | 2019-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201809450VA (en) | Heterogeneous polypeptide expression cassette | |
EP3303403A4 (en) | Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin | |
WO2019046766A3 (en) | End-to-end cell therapy automation | |
MY181199A (en) | Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use | |
PH12020550529A1 (en) | Recombinant bacterium capable of producing l-lysine, construction method thereof and production method of l-lysine | |
MY192918A (en) | Combination therapies with anti-cd38 antibodies | |
MX2018014043A (en) | Cell culture compositions with antioxidants and methods for polypeptide production. | |
IL230750B (en) | Ground robot drive system | |
MX2016013382A (en) | Method and apparatus for controlling cell aggregation. | |
MY176294A (en) | Antibodies comprising chimeric constant domains | |
PH12014501476A1 (en) | Systems and methods to transmit configuration change messages between an access point and a station | |
MX2019003427A (en) | Cell culture compositions and methods for polypeptide production. | |
WO2014144210A3 (en) | Competitive growth and/or productivity advantage for butanologen microorganism | |
MX2015012487A (en) | Control of growth-induction-production phases. | |
MX2014008441A (en) | Clostridium histolyticum enzymes and methods for the use thereof. | |
MX2016015214A (en) | Apparatus and method. | |
EP3263697A4 (en) | Culture medium for culturing mesenchymal stem cell, method for culturing mesenchymal stem cell, and mesenchymal stem cell | |
MX2020003508A (en) | A protein secretory factor with high secretory efficiency and an expression vector comprising the same. | |
MX2016000634A (en) | Optimised method for breaking chlorella cell walls by means of very high pressure homogenisation. | |
EA201592169A1 (en) | RECOMBINANT MICROORGANISMS WHICH ARE INCREASING A FLOW THROUGH THE ENZYMING WAY | |
AU2015348922A8 (en) | Codon optimized polynucleotide for high level expression of CRM197 | |
MX2017005925A (en) | Methods of producing two chain proteins in bacteria. | |
MY168287A (en) | Cow rumen xylose isomerases active in yeast cells | |
EP3230457A4 (en) | Clostridial neurotoxin fusion proteins, propeptide fusions, their expression, and use | |
MX2015011781A (en) | Cell culture media and methods of antibody production. |